Latest filing published 25 Feb 2026 for Vera Therapeutics, Inc., €76k.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Robert Brenner: trading record in brief
Robert Brenner appears in our data through filings on Vera Therapeutics, Inc. shares, published by SEC (Form 4). Between 18 February 2025 and 23 February 2026, the trades on record add up to 3 filings.
On the market, this insider has only sold: 1 sale, €76k in total. Outside the open market, there are 2 share grants. So far in 2026, the count stands at no purchases and 1 sale.
Most recently, on 25 February 2026, the filings show an open-market sale worth €76k in Vera Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Robert Brenner
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,151 shares@ US$41.9839Class A Common StockSEC:0002006910-26-000004:0
- 25,000 shares0Class A Common StockSEC:0002006910-26-000002:0
- 26,900 shares0Class A Common StockSEC:0001415889-25-004847:0
3 of 3 declarations
